Vredenburgh, J. J., Desjardins, A., Reardon, D. A., Peters, K. B., Herndon, J. E., Marcello, J., . . . Friedman, H. S. (2011). The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma.

Vredenburgh, James J., et al. The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed By Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma. 2011.

Vredenburgh, James J., et al. The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed By Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma. 2011.